1977
DOI: 10.1007/bf00469742
|View full text |Cite
|
Sign up to set email alerts
|

Bioplast� fibrin implants in nasoseptal perforation

Abstract: This study includes 9 cases of nasoseptal perforation following submucous septectomy. Sheets from Bioplast fibrin, an absorbable biomaterial, were implanted to prevent thepersistence of perforations. Postoperative mucosal growth on both implant surfaces ensured closure in 6 of the 9 cases. The method has the advantage of simplicity and it is commendable in the case of smaller defects when the mucosa is not markedly atrophic.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1980
1980
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…Hungarian government. [68][69][70][71][72][73][74] The Hungarian IP was sold to Ethicon in the early mid 1970s, and the technology was shelved due to the advent of modern plastics as well as new concerns over the bovine-derived products. Cost was also an issue due to the high cost of isolating the large volumes of fibrinogen needed to make such plastics.…”
Section: Plasma-based Biomaterials For Tissue Repairmentioning
confidence: 99%
“…Hungarian government. [68][69][70][71][72][73][74] The Hungarian IP was sold to Ethicon in the early mid 1970s, and the technology was shelved due to the advent of modern plastics as well as new concerns over the bovine-derived products. Cost was also an issue due to the high cost of isolating the large volumes of fibrinogen needed to make such plastics.…”
Section: Plasma-based Biomaterials For Tissue Repairmentioning
confidence: 99%
“…Suggestions concerning the use of artificial material or implants associated with closure techniques were given by Gyeney and Kerenyi 20 who in 1977 reported the closure of septal perforation through fibrin implants (Bioplast®). Kridel et al in 1998 21 suggested the use of a biosynthetic substitute (Acellular Human Dermal Allograft®), having reported success in the closure of eleven among 12 perforations treated.…”
Section: Literature Reviewmentioning
confidence: 99%